Ser285
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.7.9
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Ser285  -  TCEB3 (human)

Site Information
EENRRPPsGDNAREK   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 18914150

In vivo Characterization
Methods used to characterize site in vivo:
immunoassay ( 1 ) , mass spectrometry ( 1 , 2 ) , mutation of modification site ( 1 ) , phospho-antibody ( 1 ) , western blotting ( 1 )
Disease tissue studied:
bone cancer ( 1 )
Relevant cell line - cell type - tissue:
293 (epithelial) ( 1 ) , HUES-9 ('stem, embryonic') ( 2 ) , U2OS (bone cell) ( 1 )

Upstream Regulation
Putative in vivo kinases:
CDKL5 (human) ( 1 )
Kinases, in vitro:
CDKL5 (human) ( 1 )
Treatments:
DRB ( 1 ) , olaparib ( 1 ) , siRNA ( 1 )

References 

1

Khanam T, et al. (2021) CDKL5 kinase controls transcription-coupled responses to DNA damage. EMBO J 40, e108271
34605059   Curated Info

2

Rigbolt KT, et al. (2011) System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation. Sci Signal 4, rs3
21406692   Curated Info

Developed with grants from  NIH Logo and literature mining with Linguamatics  I2E Logo Creative Commons License PhosphoSite, created by Cell Signaling Technology is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.

©2003-2024 Cell Signaling Technology, Inc.